MetaCap

Aardvark Therapeutics Statistics

NASDAQ: AARDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.9226-0.0774 (-7.74%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Aardvark Therapeutics by the numbers

Aardvark Therapeutics has a market capitalization of $20.2 million based on 21.89M shares outstanding. With trailing EPS of $-3.33, Aardvark Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 72.4% below its 50-day average and 82.8% below its 200-day average.

Average daily trading volume is 643.53K shares, or about $593,724 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AARD valuation vs. peer median

AARD compared with the median of 8 peer companies
MetricAARDPeer medianDifference
Market cap$20.20M$19.70M+3%
Avg. volume643.53K380.08K+69%

Peer median across 8 companies: RNAZ, ACET, TXMD, IGC, CPHI, CRVO, COCP, MRKR.

Valuation

Price and trading

Previous close
1.00
Open
1.00
Day range
0.90 – 1.06
52-week range
0.90 – 16.60
52-week change
-90.15%
Beta
—
Volume
241.07K

Dividends and events

Annual dividend
None
Next earnings date
Nov 13, 2026

Additional statistics

Market Cap
20.20M
Forward Pe
-0.39
Eps
-3.33
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
16.60
Week52 Low
0.90
Avg Volume
643.53K
Shares Outstanding
21.89M
Ma50
3.35
Ma200
5.36
Earnings Date
Nov 13, 2026
Pct From52w High
-94.44%
Pct From52w Low
2.51%

Related